Noble VictoriesNoble Victories🃏All Frillish cards
Ask about Frillish
Frillish #30 Pokémon card from Noble Victories

Frillish 30/101

Noble Victories

Find this card on eBay

Affiliate link · we may earn commission

Frillish #30 from Noble Victories currently trades at $1.03 raw, with PSA 10 copies reaching $44.34 — a 43.0x grade premium.
Current Prices (USD)
Ungraded
$1.03
PSA 7
$16.14
PSA 8
$16.14
PSA 9
$16.14
PSA 10
$44.34
ACE 10
BGS 10 Black
$290.00
CGC 10 Pristine
$49.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Frillish 30/101 from Noble Victories has a current raw market value of $1.03.

Current raw value
$1.03
PSA 9 value
$16.14
PSA 10 value
$44.34
PSA 10 premium vs raw
43.0× raw
View all cards from Noble Victories
Collector Intel
43.0x
Raw → PSA 10
High-risk grade
15.7x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 43x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$44
PSA 10 Value
+$18
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1615.7x raw
PSA 10$4443.0x raw

Frequently asked questions

How much is Frillish #30 from Noble Victories worth?+
Frillish #30 from Noble Victories is currently worth Raw: $1.03, PSA 9: $16.14, PSA 10: $44.34 based on recent sold listings. Prices update daily from real eBay sales.
Is Frillish #30 worth grading?+
The PSA 10 price of $44.34 is 43.0× the raw price of $1.03. After a ~$25 grading fee, a PSA 10 result would net approximately $43.31 — assuming the card grades a 10.
Where do PokePrices Frillish #30 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.